PA MedTech VC Fund
Overview
PA MedTech VC Fund is a corporate venture fund of Picard Angst that makes direct investments in medical technology start-ups, with a particular focus on the cardiovascular and ophthalmology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Supira Medical | Mar 2025 | Series E | Co-investor |
| Akura Medical | Dec 2025 | Series C | Co-investor |
| Adona Medical | Apr 2022 | Series B | Co-investor |
| Tioga Cardiovascular | Feb 2023 | Series C | Co-investor |
| Myra Vision | Jun 2023 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is PA MedTech VC Fund based?
PA MedTech VC Fund is headquartered in Pfäffikon, Switzerland.
When was PA MedTech VC Fund founded?
PA MedTech VC Fund was founded in 2021.
How many portfolio companies does PA MedTech VC Fund have?
PA MedTech VC Fund has 7 portfolio companies in Caplight's dataset.
What are some companies in PA MedTech VC Fund's portfolio?
Portfolio companies visible on Caplight include Supira Medical, Akura Medical, Adona Medical, Tioga Cardiovascular, Myra Vision.
What was PA MedTech VC Fund's most recent investment shown here?
PA MedTech VC Fund's most recent investment in this portfolio sample was in Akura Medical in 2025.
What sectors does PA MedTech VC Fund focus on?
PA MedTech VC Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does PA MedTech VC Fund focus on?
Stage focus information for PA MedTech VC Fund is not publicly available.